Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2026-01-28 @ 10:45 PM
Study NCT ID:
NCT00833261
Status:
COMPLETED
Last Update Posted:
2020-08-21
First Post:
2009-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent hypopharynx Cancer | View |
| None | recurrent larynx Cancer | View |
| None | recurrent verrucous carcinoma | View |
| None | squamous cell carcinoma | View |
| None | recurrent oral cavity cancer | View |
| None | recurrent metastatic occult primary cancer | View |
| None | recurrent oropharynx cacner | View |
| None | recurrent paranasal sinus and nasal cavity cancer | View |
| None | tongue cancer | View |